Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/idempotent annotations, the description discloses graceful degradation when GLEIF/OpenFIGI are unavailable, explicit `unresolved` handling, non-assertive behavior when ambiguous matches occur with `figi_candidates`, source-labelled identifiers, and the cascading internal lookup behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but densely informative, covering many edge cases an agent would otherwise need to discover through failure. It is somewhat run-on in places, but the structure is front-loaded with intent and each section adds meaningful guidance rather than filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description fully covers input constraints, return value behavior, ambiguity handling, unresolved identifiers, enrichment degradation, and the internal cascade of lookups. An agent has everything needed to invoke it correctly across edge cases.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and the description adds substantial value beyond the schema by explaining accepted input forms (ticker, CIK, ISIN, name), the ISIN-to-LEI mapping, the important 'ENTITY NAME ONLY' caveat with a concrete example, and why trailing security-class words fail the FIGI lookup.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete trigger phrases and states the core purpose: resolving a user-spoken name to canonical/official identifiers that other tools require as input. It clearly differentiates itself by specifying supported entity types (company, drug) and the exact identifier families it returns (CIK, ticker, LEI, FIGI, RxCUI).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit directive: 'Use FIRST whenever you have a name but need an ID.' It also explains when resolution is appropriate even for non-equity instruments and notes that the tool replaces multiple manual lookups, giving clear context for agent selection.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

C2.6/5.0
Disambiguation3/5

Tools like ask_pipeworx, ask_pipeworx_grounded, deep_research, and entity_profile have overlapping purposes, causing potential confusion. However, their descriptions provide some differentiation, so an agent can usually pick the right one with careful reading.

Naming Consistency2/5

Naming is highly inconsistent: mixes verb_noun (ask_pipeworx), noun_verb (reverse_dns), single-word (geoip), and compound phrases (generate_llms_txt). No clear pattern, making it hard for an agent to predict tool names.

Tool Count2/5

44 tools is overwhelmingly high for a single server. The set mixes unrelated domains (network tools, data APIs, memory, prediction markets), suggesting it's a grab bag rather than a focused toolkit.

Completeness2/5

The server lacks a coherent domain, so evaluating completeness is difficult. There are many lookup tools but few for updates or deletes (except memory). The HackerTarget subset is sparse, and the overall surface feels incomplete for any single purpose.